Pulse Biosciences has developed a system for delivering nanosecond pulsed electrical energy with enhanced safety and robust operation. The system includes a treatment controller, nanosecond pulse generator, handpiece subsystem, and interface board with EMI-filtered, transient protected, and high-voltage isolation barriers for improved performance. GlobalData’s report on Pulse Biosciences gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Pulse Biosciences Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Pulse Biosciences, Target mapping ablation catheters was a key innovation area identified from patents. Pulse Biosciences's grant share as of February 2024 was 62%. Grant share is based on the ratio of number of grants to total number of patents.

System for delivering nanosecond pulsed electrical energy with enhanced safety

Source: United States Patent and Trademark Office (USPTO). Credit: Pulse Biosciences Inc

A recently granted patent (Publication Number: US11904164B2) discloses a system for delivering nanosecond pulsed electrical energy. The system includes a treatment controller, a nanosecond pulse generator, a handpiece subsystem, and an interface board with EMI-filtered, transient protected, and high-voltage isolation barriers. All power and communications between the nanosecond pulse generator and the handpiece subsystem or treatment controller pass through these barriers. The nanosecond pulse generator is designed with specific circuit sections that are electrically isolated from each other by multi-function isolation connections with a capacitance of 20 pF or less.

Moreover, the system involves a method for delivering nanosecond pulsed electrical energy, where system power and pulse generator power are provided from a system power supply to an interface board with high-voltage isolation barriers. User input is received through a treatment controller, and all communications to and from the nanosecond pulse generator are transmitted through the high-voltage isolation barriers of the interface board. The high voltage pulsed output is delivered to the handpiece through these barriers based on the user input, with additional steps to isolate and filter communications and system power to the handpiece subassembly. The nanosecond pulse generator is capable of providing high voltage pulsed output with specific voltage and current parameters, ensuring authenticity of the handpiece and treatment tip, and calculating critical pulse metrics from the output.

To know more about GlobalData’s detailed insights on Pulse Biosciences, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.